﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Cardiovascular and Thoracic Research</JournalTitle>
      <Issn>2008-5117</Issn>
      <Volume>15</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>06</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The relationship of myocardial and liver T2* values with cardiac function and laboratory findings in transfusion-dependent thalassemia major patients: A retrospective cardiac MRI study</ArticleTitle>
    <FirstPage>86</FirstPage>
    <LastPage>92</LastPage>
    <ELocationID EIdType="doi">10.34172/jcvtr.2023.31592</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Abdi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1907-9471</Identifier>
      </Author>
      <Author>
        <FirstName>Negar</FirstName>
        <LastName>Taheri</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3578-0516</Identifier>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Zahedi Haghighi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-1831-3649</Identifier>
      </Author>
      <Author>
        <FirstName>Mahya</FirstName>
        <LastName>Khaki</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5191-0384</Identifier>
      </Author>
      <Author>
        <FirstName>Homa</FirstName>
        <LastName>Najafi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-1573-9698</Identifier>
      </Author>
      <Author>
        <FirstName>Mohammad Mehdi</FirstName>
        <LastName>Hemmati Komasi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6221-2031</Identifier>
      </Author>
      <Author>
        <FirstName>Behrooz</FirstName>
        <LastName>Hassani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-2243-3187</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jcvtr.2023.31592</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2022</Year>
        <Month>06</Month>
        <Day>21</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>05</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Cardiac complications are the leading cause of death in thalassemia patients. It is assumed that progressive iron accumulation results in myocyte damage. Myocardial T2* measurement by cardiac MRI quantifies iron overload. We aimed to study the association between left and right ventricular (LV and RV) function and iron deposition estimation by cardiac MRI T2* in a sample of Iranian patients. Methods: Cardiac MRI exams of 118 transfusion-dependent thalassemia major patients were evaluated retrospectively. Biventricular function and volume and myocardial and liver T2* values were measured. The demographic and lab data were registered. Poisson and chi-square regression analyses investigated the correlation between the T2* value and ventricular dysfunction. Results: The study participants’ mean (SD) age was 32.7y (9.02), and 47.46% were female. Forty-nine cases (41.52%) revealed at least uni-ventricular dysfunction. LV dysfunction was noted in 20 cases, whereas 47 patients revealed RV dysfunction. The risk of LV dysfunction was 5.3-fold higher in patients with cardiac T2* value less than 10msec (RR=5.3, 95% CI=1.6, 17.1, P&lt;0.05). No association was found between age, liver T2* value, serum ferritin level, and chelation therapy with the risk of LV and RV dysfunction. Conclusion: Cardiac MRI T2* measure is a good indicator of LV dysfunction. Moreover, MRI parameters, especially RV functional measures, may have a substantial role in patient management. Therefore, cardiac MRI should be included in beta-thalassemia patients’ management strategies.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Cardiac MRI</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">T2* Value</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Thalassemia Major</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ventricular Function</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>